Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma JN Brudno, N Lam, D Vanasse, Y Shen, JJ Rose, J Rossi, A Xue, A Bot, ... Nature medicine 26 (2), 270-280, 2020 | 227 | 2020 |
Allogeneic lymphocytes induce tumor regression of advanced metastatic breast cancer MR Bishop, DH Fowler, D Marchigiani, K Castro, C Kasten-Sportes, ... Journal of Clinical Oncology 22 (19), 3886-3892, 2004 | 132 | 2004 |
Elevated pretransplant ferritin is associated with a lower incidence of chronic graft‐versus‐host disease and inferior survival after myeloablative allogeneic … A Mahindra, B Bolwell, R Sobecks, L Rybicki, B Pohlman, R Dean, ... British journal of haematology 146 (3), 310-316, 2009 | 122 | 2009 |
Association of serum interleukin-7 levels with the development of acute graft-versus-host disease RM Dean, T Fry, C Mackall, SM Steinberg, F Hakim, D Fowler, J Odom, ... Journal of Clinical Oncology 26 (35), 5735, 2008 | 110 | 2008 |
Patients mobilizing large numbers of CD34+ cells (‘super mobilizers’) have improved survival in autologous stem cell transplantation for lymphoid malignancies BJ Bolwell, B Pohlman, L Rybicki, R Sobecks, R Dean, J Curtis, ... Bone marrow transplantation 40 (5), 437-441, 2007 | 102 | 2007 |
Evaluation of noncytotoxic DNMT1-depleting therapy in patients with myelodysplastic syndromes Y Saunthararajah, M Sekeres, A Advani, R Mahfouz, L Durkin, ... The Journal of clinical investigation 125 (3), 1043-1055, 2015 | 95 | 2015 |
Clinical evidence of a graft-versus-lymphoma effect against relapsed diffuse large B-cell lymphoma after allogeneic hematopoietic stem-cell transplantation MR Bishop, RM Dean, SM Steinberg, J Odom, SZ Pavletic, C Chow, ... Annals of oncology 19 (11), 1935-1940, 2008 | 86 | 2008 |
NCCN guidelines insights: Hodgkin lymphoma, version 1.2018 RT Hoppe, RH Advani, WZ Ai, RF Ambinder, P Aoun, P Armand, CM Bello, ... Journal of the National Comprehensive Cancer Network 16 (3), 245-254, 2018 | 68 | 2018 |
Autologous hematopoietic stem cell transplantation in peripheral T-cell lymphoma using a uniform high-dose regimen SD Smith, BJ Bolwell, LA Rybicki, S Brown, R Dean, M Kalaycio, ... Bone marrow transplantation 40 (3), 239-243, 2007 | 68 | 2007 |
Elevated ferritin is associated with relapse after autologous hematopoietic stem cell transplantation for lymphoma A Mahindra, B Bolwell, R Sobecks, L Rybicki, B Pohlman, R Dean, ... Biology of Blood and Marrow Transplantation 14 (11), 1239-1244, 2008 | 66 | 2008 |
Vitamin D level after allogeneic hematopoietic stem cell transplant L Sproat, B Bolwell, L Rybicki, R Dean, R Sobecks, B Pohlman, ... Biology of Blood and Marrow Transplantation 17 (7), 1079-1083, 2011 | 61 | 2011 |
Autologous stem cell transplant for early relapsed/refractory Hodgkin lymphoma: results from two transplant centres SD Smith, CH Moskowitz, R Dean, B Pohlman, R Sobecks, E Copelan, ... British journal of haematology 153 (3), 358-363, 2011 | 60 | 2011 |
Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma T Radivoyevitch, RM Dean, BE Shaw, R Brazauskas, HR Tecca, ... Leukemia research 74, 130-136, 2018 | 59 | 2018 |
Risk factors for vancomycin-resistant enterococcus bacteremia and its influence on survival after allogeneic hematopoietic cell transplantation M Tavadze, L Rybicki, S Mossad, R Avery, M Yurch, B Pohlman, H Duong, ... Bone marrow transplantation 49 (10), 1310-1316, 2014 | 57 | 2014 |
Survival of AML patients receiving HLA-matched sibling donor allogeneic bone marrow transplantation correlates with HLA-Cw ligand groups for killer immunoglobulin-like receptors RM Sobecks, EJ Ball, JP Maciejewski, LA Rybicki, S Brown, M Kalaycio, ... Bone marrow transplantation 39 (7), 417-424, 2007 | 57 | 2007 |
Elevated pretransplant serum ferritin is associated with inferior survival following nonmyeloablative allogeneic transplantation A Mahindra, R Sobecks, L Rybicki, B Pohlman, R Dean, S Andresen, ... Bone marrow transplantation 44 (11), 767-768, 2009 | 56 | 2009 |
Graft-versus-host disease: emerging concepts in prevention and therapy. RM Dean, MR Bishop Current hematology reports 2 (4), 287-294, 2003 | 54 | 2003 |
The non‐relapse mortality rate for patients with diffuse large B‐cell lymphoma is greater than relapse mortality 8 years after autologous stem cell transplantation and is … BT Hill, L Rybicki, BJ Bolwell, S Smith, R Dean, M Kalaycio, B Pohlman, ... British journal of haematology 152 (5), 561-569, 2011 | 52 | 2011 |
Fludarabine as a risk factor for poor stem cell harvest, treatment-related MDS and AML in follicular lymphoma patients after autologous hematopoietic cell transplantation J Waterman, L Rybicki, B Bolwell, E Copelan, B Pohlman, J Sweetenham, ... Bone marrow transplantation 47 (4), 488-493, 2012 | 51 | 2012 |
Assessment of the hematopoietic cell transplantation comorbidity index in non-Hodgkin lymphoma patients receiving reduced-intensity allogeneic hematopoietic stem cell … SM Pollack, SM Steinberg, J Odom, RM Dean, DH Fowler, MR Bishop Biology of Blood and Marrow Transplantation 15 (2), 223-230, 2009 | 48 | 2009 |